158 related articles for article (PubMed ID: 28056849)
21. Factors associated with serum hepatitis B surface antigen levels and its on-treatment changes in patients under lamivudine therapy.
Chen J; Wang Z; Zhou B; Wang Y; Hou J
Antivir Ther; 2012; 17(1):71-9. PubMed ID: 22267471
[TBL] [Abstract][Full Text] [Related]
22. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients.
Zhang ZQ; Shi BS; Lu W; Liu DP; Huang D; Feng YL
Gastroenterol Hepatol; 2020 Nov; 43(9):526-536. PubMed ID: 32921478
[TBL] [Abstract][Full Text] [Related]
23. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B.
Kim YJ; Cho HC; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
Liver Int; 2011 Jul; 31(6):817-23. PubMed ID: 21645212
[TBL] [Abstract][Full Text] [Related]
24. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA
Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients.
Jiang B; Su R; Ren D; Zheng X; Cao Y; Mi Y; Wang F; Ma P
Virus Res; 2020 Dec; 290():198117. PubMed ID: 32800804
[TBL] [Abstract][Full Text] [Related]
26. Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients.
Chen GY; Zhu MF; Zheng DL; Bao YT; Wang J; Zhou X; Lou GQ
World J Gastroenterol; 2014 Jul; 20(25):8195-200. PubMed ID: 25009392
[TBL] [Abstract][Full Text] [Related]
27. [Changes in HBsAg titer and HBV DNA load and their correlation in patients with chronic hepatitis B and HBV-related liver cirrhosis].
Yu X; Guo R; Ke S; Huang Q; Lin C; Lin Z; Chen S; Li J; Yang P; Su Z
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):682-6. PubMed ID: 26018262
[TBL] [Abstract][Full Text] [Related]
28. A paucity of liver disease in Canadian Inuit with chronic hepatitis B virus, subgenotype B6 infection.
Minuk GY; Macrury S; Uhanova J; Caouette S; Coleman N; Cummings K; Larke B; Vardy L; Triet Huyn C; Osiowy C
J Viral Hepat; 2013 Dec; 20(12):890-6. PubMed ID: 24304459
[TBL] [Abstract][Full Text] [Related]
29. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
[TBL] [Abstract][Full Text] [Related]
30. Do the circulating Pre-S/S quasispecies influence hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
Cavallone D; Ricco G; Oliveri F; Colombatto P; Moriconi F; Coco B; Romagnoli V; Salvati A; Surace L; Bonino F; Brunetto MR
Aliment Pharmacol Ther; 2020 Jun; 51(12):1406-1416. PubMed ID: 32390175
[TBL] [Abstract][Full Text] [Related]
31. Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels.
Ormeci A; Aydın Y; Sumnu A; Baran B; Soyer OM; Pınarbasi B; Gokturk S; Gulluoglu M; Onel D; Badur S; Akyuz F; Karaca C; Demir K; Besisik F; Kaymakoglu S
Int J Infect Dis; 2016 Nov; 52():68-73. PubMed ID: 27619844
[TBL] [Abstract][Full Text] [Related]
32. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
[TBL] [Abstract][Full Text] [Related]
34. Short-term spontaneous fluctuations of HBV DNA levels in a Senegalese population with chronic hepatitis B.
Maylin S; Sire JM; Mbaye PS; Simon F; Sarr A; Evra ML; Fall F; Daveiga J; Diallo A; Debonne JM; Chartier L; Vray M
BMC Infect Dis; 2015 Mar; 15():154. PubMed ID: 25887383
[TBL] [Abstract][Full Text] [Related]
35. Correlation between hepatitis B surface antigen titers and HBV DNA levels.
Alghamdi A; Aref N; El-Hazmi M; Al-Hamoudi W; Alswat K; Helmy A; Sanai FM; Abdo AA
Saudi J Gastroenterol; 2013; 19(6):252-7. PubMed ID: 24195978
[TBL] [Abstract][Full Text] [Related]
36. Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.
Liu J; Yang HI; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Chen CJ
Hepatology; 2016 Aug; 64(2):381-9. PubMed ID: 27079545
[TBL] [Abstract][Full Text] [Related]
37. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum quantitative HBsAg and HBV DNA levels in chronic hepatitis B patients.
Yang N; Feng J; Zhou T; Li Z; Chen Z; Ming K; Liang G; Lei XX; Xu BL
J Med Virol; 2018 Jul; 90(7):1240-1245. PubMed ID: 29603789
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
Chung KH; Kim W; Kim BG; Lee HY; Jin E; Cho Y; Seo JY; Kim HY; Jung YJ; Kim JW; Jeong JB; Lee KL
Gut Liver; 2015 Sep; 9(5):657-64. PubMed ID: 25717049
[TBL] [Abstract][Full Text] [Related]
40. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
